- Home
- HOV vs SANA Comparison
HOV vs SANA Comparison
Compare HOV & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOV
- SANA
- Stock Information
- Founded
- HOV 1959
- SANA 2018
- Country
- HOV United States
- SANA United States
- Employees
- HOV N/A
- SANA N/A
- Industry
- HOV Homebuilding
- SANA Medicinal Chemicals and Botanical Products
- Sector
- HOV Consumer Discretionary
- SANA Health Care
- Exchange
- HOV Nasdaq
- SANA Nasdaq
- Market Cap
- HOV 606.2M
- SANA 719.5M
- IPO Year
- HOV N/A
- SANA 2021
- Fundamental
- Price
- HOV $106.47
- SANA $4.54
- Analyst Decision
- HOV Sell
- SANA Strong Buy
- Analyst Count
- HOV 2
- SANA 6
- Target Price
- HOV $120.00
- SANA $10.00
- AVG Volume (30 Days)
- HOV 257.4K
- SANA 6.7M
- Earning Date
- HOV 08-21-2025
- SANA 08-07-2025
- Dividend Yield
- HOV N/A
- SANA N/A
- EPS Growth
- HOV N/A
- SANA N/A
- EPS
- HOV 28.18
- SANA N/A
- Revenue
- HOV $3,062,436,000.00
- SANA N/A
- Revenue This Year
- HOV $0.00
- SANA N/A
- Revenue Next Year
- HOV $2.50
- SANA N/A
- P/E Ratio
- HOV $3.79
- SANA N/A
- Revenue Growth
- HOV 7.85
- SANA N/A
- 52 Week Low
- HOV $81.15
- SANA $1.26
- 52 Week High
- HOV $240.34
- SANA $7.30
- Technical
- Relative Strength Index (RSI)
- HOV 51.26
- SANA 81.43
- Support Level
- HOV $105.00
- SANA $2.60
- Resistance Level
- HOV $112.01
- SANA $4.45
- Average True Range (ATR)
- HOV 6.56
- SANA 0.33
- MACD
- HOV -0.84
- SANA 0.09
- Stochastic Oscillator
- HOV 29.87
- SANA 92.65
About HOV Hovnanian Enterprises Inc.
Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations . The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments; Northeast which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia and West Virginia; Southeast which includes Florida, Georgia and South Carolina; and West which includes Arizona, California and Texas. The firm generates maximum revenue from West Segment.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.